The detection rate for prostate cancer in systematic and targeted prostate biopsy in biopsy‐naive patients, according to the localization of the lesion at the mpMRI: A single‐center retrospective observational study

Matteo Massanova,Biagio Barone,Vincenzo Francesco Caputo,Luigi Napolitano,Andrea Ponsiglione,Francesco Del Giudice,Matteo Ferro,Giuseppe Lucarelli,Francesco Lasorsa,Gian Maria Busetto,Sophie Robertson,Francesco Trama,Ciro Imbimbo,Felice Crocetto
DOI: https://doi.org/10.1002/pros.24761
2024-06-27
The Prostate
Abstract:Objective Evaluate the detection rates of systematic, targeted and combined cores at biopsy according to tumor positions in biopsy‐naïve patients. Material and Methods A retrospective analysis of a single‐center patient cohort (n = 501) that underwent transrectal prostate biopsy between January 2017 and December 2019 was performed. Multi‐parametric MRI was executed as a prebiopsy investigation. Biopsy protocol included, for each patient, 12 systematic cores plus 3 to 5 targeted cores per lesion identified at the mpMRI. Pearson and McNemar chi‐squared tests were used for statistical analysis to compare tumor location‐related detection rates of systematic, targeted and combined (systematic + targeted) cores at biopsy. Results Median age of patients was 70 years (IQR 62–72), with a median PSA of 8.5 ng/ml (IQR 5.7–15.6). Positive biopsies were obtained in 67.7% of cases. Overall, targeted cores obtained higher detection rates compared to systematic cores (54.3% vs. 43.1%, p
endocrinology & metabolism,urology & nephrology
What problem does this paper attempt to address?